Published in Surg Endosc on February 27, 2011
Changes in gene expression of neo-squamous mucosa after endoscopic treatment for dysplastic Barrett's esophagus and intramucosal adenocarcinoma. United European Gastroenterol J (2016) 0.75
Ki-67 and Bax expression in esophageal mucosa might have implications in ablative therapies for Barrett's esophagus, dysplasia, and adenocarcinoma. Surg Endosc (2012) 0.75
Intramucosal adenocarcinoma arising under squamous re-epithelialisation of Barrett's oesophagus. Gut (2000) 3.83
Incidence of esophageal adenocarcinoma in patients with Barrett's esophagus and high-grade dysplasia: a meta-analysis. Gastrointest Endosc (2007) 2.77
Individual crypt genetic heterogeneity and the origin of metaplastic glandular epithelium in human Barrett's oesophagus. Gut (2008) 2.51
The incidence of esophageal cancer and high-grade dysplasia in Barrett's esophagus: a systematic review and meta-analysis. Am J Epidemiol (2008) 2.34
Effective treatment of early Barrett's neoplasia with stepwise circumferential and focal ablation using the HALO system. Endoscopy (2008) 1.71
Prevention of the neoplastic progression of Barrett's oesophagus by endoscopic argon beam plasma ablation. Br J Surg (2001) 1.63
Argon beam plasma coagulation as therapy for high-grade dysplasia in Barrett's esophagus. Clin Gastroenterol Hepatol (2003) 1.55
MicroRNA-196a is a potential marker of progression during Barrett's metaplasia-dysplasia-invasive adenocarcinoma sequence in esophagus. Am J Pathol (2009) 1.51
Histopathology of Barrett's esophagus after ablation and endoscopic mucosal resection therapy. Endoscopy (2008) 1.45
Barrett's oesophagus: from metaplasia to dysplasia and cancer. Gut (2005) 1.18
Long-term follow-up of complete Barrett's eradication endoscopic mucosal resection (CBE-EMR) for the treatment of high grade dysplasia and intramucosal carcinoma. Endoscopy (2007) 1.16
Endoscopic mucosal resection for high-grade dysplasia and intramucosal carcinoma in Barrett's esophagus: an Italian experience. World J Gastroenterol (2005) 1.10
Buried Barrett's epithelium following photodynamic therapy shows reduced crypt proliferation and absence of DNA content abnormalities. Am J Gastroenterol (2007) 1.04
Barrett's oesophagus and oesophageal adenocarcinoma: how does acid interfere with cell proliferation and differentiation? Gut (2005) 1.03
Endoscopic ablation of dysplastic Barrett's oesophagus comparing argon plasma coagulation and photodynamic therapy: a randomized prospective trial assessing efficacy and cost-effectiveness. Scand J Gastroenterol (2005) 1.01
Radiofrequency ablation for total Barrett's eradication: a description of the endoscopic technique, its clinical results and future prospects. Endoscopy (2008) 0.97
Bax upregulation may provide a rationale for the low incidence of esophageal adenocarcinoma in a Greek cohort of patients with Barrett's esophagus. Hepatogastroenterology (2007) 0.84
Photodynamic therapy with curative intent for Barrett's esophagus with high grade dysplasia and superficial esophageal cancer. Ann Surg Oncol (2007) 0.83
Abnormal expression of biomarkers in incompletely ablated Barrett's esophagus. Ann Surg (2006) 0.82
Postprandial changes in small bowel water content in healthy subjects and patients with irritable bowel syndrome. Gastroenterology (2009) 1.97
Argon beam plasma coagulation as therapy for high-grade dysplasia in Barrett's esophagus. Clin Gastroenterol Hepatol (2003) 1.55
A plasma membrane H+-ATPase is required for the formation of proanthocyanidins in the seed coat endothelium of Arabidopsis thaliana. Proc Natl Acad Sci U S A (2005) 1.52
Uterine innervation after hysterectomy for chronic pelvic pain with, and without, endometriosis. Am J Obstet Gynecol (2005) 1.11
Nuclear organization and chromatin dynamics--Sp1, Sp3 and histone deacetylases. Adv Enzyme Regul (2008) 1.09
Chromatin organization and nuclear microenvironments in cancer cells. J Cell Biochem (2008) 0.92
An unusual complication of Burch colposuspension. Int J Urol (2004) 0.87
Studies of the human oropharyngeal airspaces using magnetic resonance imaging. I. Validation of a three-dimensional MRI method for producing ex vivo virtual and physical casts of the oropharyngeal airways during inspiration. J Aerosol Med (2003) 0.85
Genomic instability and histone H3 phosphorylation induction by the Ras-mitogen activated protein kinase pathway in pancreatic cancer cells. Int J Cancer (2009) 0.79
Pneumothorax as a presenting feature of granulomatous disease of the lung in a patient with Crohn's disease. Eur J Gastroenterol Hepatol (2009) 0.77
Transition metal ion-substituted polyoxometalates entrapped in polypyrrole as an electrochemical sensor for hydrogen peroxide. Analyst (2011) 0.75
Titania-silver and alumina-silver composite nanoparticles: novel, versatile synthesis, reaction mechanism and potential antimicrobial application. J Colloid Interface Sci (2011) 0.75
Re-establishing functionality and aesthetics after severe burns over the proximal interphalangeal joint using the cross-digital dorsal adipofascial flap. Burns (2011) 0.75
Eosinophilic gastritis with idiopathic thrombocytopaenic purpura: coincidence or association? Eur J Gastroenterol Hepatol (2009) 0.75
Investigations into the electrochemical, surface, and electrocatalytic properties of the surface-immobilized polyoxometalate, TBA3K[SiW10O36(PhPO)2]. ACS Appl Mater Interfaces (2015) 0.75
Vesical endometriosis. J Obstet Gynaecol (2004) 0.75
Surface immobilization of a tetra-ruthenium substituted polyoxometalate water oxidation catalyst through the employment of conducting polypyrrole and the layer-by-layer (LBL) technique. ACS Appl Mater Interfaces (2014) 0.75